Literature DB >> 32698959

Acute and chronic improvement in postprandial glucose metabolism by a diet resembling the traditional Mediterranean dietary pattern: Can SCFAs play a role?

Marilena Vitale1, Rosalba Giacco2, Manolo Laiola3, Giuseppe Della Pepa1, Delia Luongo4, Anna Mangione1, Dominic Salamone1, Paola Vitaglione5, Danilo Ercolini5, Angela Albarosa Rivellese6.   

Abstract

BACKGROUND & AIMS: Postprandial metabolic abnormalities are considered important and independent risk factors for cardiovascular diseases. However, the effects of the Mediterranean diet on postprandial metabolism and the mechanism underpinning the effects on clinical variables have not been exhaustively explored. Therefore, the aims of the present study were to evaluate the acute and medium-term effects (8 weeks) on postprandial glucose and lipid metabolism of a diet resembling a typical Mediterranean diet (Med-D) compared to a western-type diet (Control-D), and the mechanisms underlying those effects.
METHODS: Twenty-nine overweight/obese individuals of both genders, aged 20-60 years, were enrolled and randomly assigned to two isoenergetic dietary interventions: 1) a Med-D (n = 16), and 2) a Control-D (n = 13). Adherence to the dietary interventions was assessed by a 7-day food record. A meal test resembling the assigned diet was performed at baseline and after 8 weeks of intervention. Blood samples at fasting and over 4-h after the meal were collected to assess metabolic parameters and short chain fatty acid (SCFA) levels. Fecal samples were also collected to evaluate the microbiota composition.
RESULTS: Glucose and insulin responses were significantly reduced at baseline after the Med test meal compared to the Control meal (p < 0.05) and this effect was strengthened after 8 weeks of intervention with the Mediterranean diet (p < 0.05); together with an improvement in OGIS. At the end of the intervention, postprandial plasma butyric acid incremental area under the curve (IAUC) was significantly increased in the Med-D group (p = 0.019) and correlated inversely with plasma insulin IAUC and directly with oral glucose insulin sensitivity (OGIS) (r: -0.411, p = 0.046 and r: 0.397, p = 0.050 respectively). These metabolic changes were accompanied by significant changes in gut microbiota, such as an increase in the relative abundance of Intestinimonas butyriciproducens and Akkermansia muciniphila (p < 0.05) in the Med-D compared to Control-D group.
CONCLUSIONS: Our study provides strong evidence that a diet resembling the traditional Med-D improves postprandial glucose metabolism and insulin sensitivity. Furthermore, the study highlights a possible involvement of gut microbiota metabolites - such as butyric acid, and of dietary fiber as a precursor - in improving glucose metabolism and insulin sensitivity.
Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Glucose metabolism; Insulin sensitivity; Mediterranean diet; Microbiota; Postprandial blood glucose; Short chain fatty acids

Year:  2020        PMID: 32698959     DOI: 10.1016/j.clnu.2020.05.025

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  11 in total

1.  Circulating short-chain fatty acids in type 2 diabetic patients and overweight/obese individuals.

Authors:  Dominic Salamone; Giuseppina Costabile; Alessandra Corrado; Giuseppe Della Pepa; Marilena Vitale; Rosalba Giacco; Delia Luongo; Roberta Testa; Angela Albarosa Rivellese; Giovanni Annuzzi; Lutgarda Bozzetto
Journal:  Acta Diabetol       Date:  2022-08-03       Impact factor: 4.087

2.  Metabolic traits affecting the relationship between liver fat and intrapancreatic fat: a mediation analysis.

Authors:  Juyeon Ko; Ivana R Sequeira; Loren Skudder-Hill; Jaelim Cho; Sally D Poppitt; Maxim S Petrov
Journal:  Diabetologia       Date:  2022-10-04       Impact factor: 10.460

Review 3.  The role of the gut microbiota in health and cardiovascular diseases.

Authors:  Lu Wang; Shiqi Wang; Qing Zhang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Mol Biomed       Date:  2022-10-11

Review 4.  Intestinal Flora: A Potential New Regulator of Cardiovascular Disease.

Authors:  Yifei Zou; Xianjing Song; Ning Liu; Wei Sun; Bin Liu
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

5.  Gut dysbiosis and body composition in cirrhosis.

Authors:  Roman Maslennikov; Vladimir Ivashkin; Aliya Alieva; Elena Poluektova; Anna Kudryavtseva; George Krasnov; Maria Zharkova; Yuri Zharikov
Journal:  World J Hepatol       Date:  2022-06-27

6.  Effect of Acute Intake of Fermented Orange Juice on Fasting and Postprandial Glucose Metabolism, Plasma Lipids and Antioxidant Status in Healthy Human.

Authors:  Blanca Escudero-López; Isabel Cerrillo; Ángeles Ortega; Franz Martín; María-Soledad Fernández-Pachón
Journal:  Foods       Date:  2022-04-27

Review 7.  The gut microbiome as a modulator of healthy ageing.

Authors:  Tarini Shankar Ghosh; Fergus Shanahan; Paul W O'Toole
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-04-25       Impact factor: 73.082

Review 8.  Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.

Authors:  Piero Portincasa; Leonilde Bonfrate; Mirco Vacca; Maria De Angelis; Ilaria Farella; Elisa Lanza; Mohamad Khalil; David Q-H Wang; Markus Sperandio; Agostino Di Ciaula
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

Review 9.  Gut microbiota influence in type 2 diabetes mellitus (T2DM).

Authors:  A L Cunningham; J W Stephens; D A Harris
Journal:  Gut Pathog       Date:  2021-08-06       Impact factor: 4.181

10.  Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation.

Authors:  Silvia Tagliamonte; Manolo Laiola; Rosalia Ferracane; Marilena Vitale; Maria A Gallo; Victoria Meslier; Nicolas Pons; Danilo Ercolini; Paola Vitaglione
Journal:  Eur J Nutr       Date:  2021-03-24       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.